Bill Gates Gates Foundation Trust
Bill Gates is co-chair of the Gates Foundation, whose trust manages a large endowment portfolio disclosed in public filings. While best known as co-founder of Microsoft and a global philanthropist, the foundation trust’s equity holdings are widely followed by investors for long-term positions and occasional large rebalancings. The portfolio reflects an endowment-style approach rather than an active trading mandate.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.21B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 43.37% |
| 2 | Technology | 25.55% |
| 3 | Financials | 21.88% |
| 4 | Consumer Staples | 3.87% |
| 5 | Materials | 3.16% |
Similar funds
Bill Gates's Q1 2025 Portfolio in Review
As of Q1 2025, Bill Gates held 25 positions worth $41.8B, down 0.5% from $42B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4%. Bill Gates opened 1 new position and made no exits, leaving the 25-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 43% of assets, up from 42% a quarter earlier, followed by Technology and Financials.
- Bill Gates's largest Q1 2025 buy was West Pharmaceutical: 444,500 shares worth $99.5M.
- Bill Gates's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $1.21B.
- Bill Gates's ten largest holdings make up 96% of its $41.8B portfolio in Q1 2025.
- Bill Gates opened 1 new position and closed 0 in Q1 2025.
- Bill Gates's portfolio value fell 0.5% quarter-over-quarter to $41.8B.
Based on Gates Foundation Trust's 13F filing for Q1 2025, filed 15 May 2025.